Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades5
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- Traumakine treatment optimal for particular subgroup, Faron finds
5 Dec 2018 - Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine
5 Dec 2018 - WINNERS & LOSERS SUMMARY: McColl's Retail Plunges After Profit Warning
3 Dec 2018 - Faron Pharmaceuticals applies to begin Clevegen clinical trials
3 Dec 2018 - DIRECTOR DEALINGS: Faron Divisional Chief Medical Officer Buys Shares
6 Nov 2018 - Faron Reports Corticosteroids Interference In Traumakine Trial
22 Oct 2018 - Faron Pharmaceuticals Submits Clinical Trial Application For Clevegen
17 Sep 2018 - WINNERS & LOSERS SUMMARY: Retailers Hit As John Lewis Profit Collapses
13 Sep 2018
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
Traumakine treatment optimal for particular subgroup, Faron finds
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has identified, by genetic testing, an "optimal subgroup" of acute r...
Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine
LONDON (Alliance News) - Faron Pharmaceuticals Ltd shares jumped on Wednesday as the company said it identified an "optimal" subgroup of patients, wit...
WINNERS & LOSERS SUMMARY: McColl's Retail Plunges After Profit Warning
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 8.9%...
Faron Pharmaceuticals applies to begin Clevegen clinical trials
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that its clinical trial application to conduct a...
DIRECTOR DEALINGS: Faron Divisional Chief Medical Officer Buys Shares
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Tuesday said VP Drug Development Chief Medical Officer Matti Karvonen acquired shares in the biop...
Faron Reports Corticosteroids Interference In Traumakine Trial
LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Monday that it has found evidence suggesting that corticosteroids used in parallel to its Trau...
Faron Pharmaceuticals Submits Clinical Trial Application For Clevegen
LONDON (Alliance News) - Faron Pharmaceuticals Oy said Monday it has filed a clinical trial application for its cancer immunotherapy drug Clevegen.Cle...
WINNERS & LOSERS SUMMARY: Retailers Hit As John Lewis Profit Collapses
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNE...
Follow the stocks
